MA
GMDA

MYDA Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

MYDA Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-56,000
Closed -$470K – 346
2020
Q4 		$470K Buy
+56,000
New +$379K 0.14% 129

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MYDA Advisors's GMDA Position: Q1 2021 in Review

MYDA Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2021, closing a stake of 56,000 shares — an estimated $470K sold.

MYDA Advisors first reported a position in GMDA in Q4 2020 and held it in 1 quarter. The position peaked at $470K in Q4 2020. 73 funds tracked by Wall St. Rank hold GMDA as of Q1 2021.

  • MYDA Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • MYDA Advisors sold 56,000 Gamida Cell Ltd. Ordinary Shares shares in Q1 2021, an estimated $470K.
  • MYDA Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and held it in 1 quarter.
  • MYDA Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $470K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2021.

Based on MYDA Advisors's 13F filing for Q1 2021, filed 12 May 2021.